ABVC
ABVC Biopharma Inc
NASDAQ: ABVC · HEALTHCARE · BIOTECHNOLOGY
$1.03
-3.74% today
Updated 2026-04-29
Market cap
$26.41M
P/E ratio
—
P/S ratio
27.42x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$1 – $5
Volume
0.1M
ABVC Biopharma Inc (ABVC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
375.80%
ROE
-119.50%
ROA
-31.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2004 | $57494.00 | $2539.00 | 43.66% | 3.49% | 4.42% |
| 2005 | $17084.00 | $-26670.00 | 97.61% | -102.86% | -156.11% |
| 2006 | $41838.00 | $-25399.00 | 100.00% | -64.12% | -60.71% |
| 2007 | $41668.00 | $-4.65M | 69.38% | -10,596.38% | -11,161.73% |
| 2008 | $25092.00 | $-6.77M | -49.39% | -21,340.32% | -26,981.99% |
| 2009 | $-272000.00 | $-5.18M | 561.10% | 1,805.32% | 1,905.22% |
| 2010 | $14860.00 | $-1.90M | -204.50% | -12,715.16% | -12,793.14% |
| 2011 | $3190.00 | $-1.22M | -971.44% | -59,180.66% | -38,202.23% |
| 2014 | $7787.00 | $-24100.00 | 100.00% | -309.49% | -309.49% |
| 2015 | $3360.00 | $-32281.00 | 84.49% | -960.74% | -960.74% |
| 2016 | $32.00 | $-11.01M | -100.00% | -34,366,359.38% | -34,399,184.38% |
| 2017 | $3196.00 | $-4.24M | 29.63% | -129,497.81% | -132,755.32% |
| 2018 | $6956.00 | $-5.58M | -3,190.54% | -40,031.10% | -80,152.08% |
| 2019 | $701719.00 | $-3.64M | 97.13% | -492.90% | -518.98% |
| 2020 | $483045.00 | $-9.79M | 96.13% | -1,760.87% | -2,026.97% |
| 2021 | $355797.00 | $-12.84M | 98.57% | -3,290.07% | -3,608.47% |
| 2022 | $969783.00 | $-16.42M | 70.47% | -1,558.54% | -1,693.50% |
| 2023 | $152430.00 | $-7.79M | -98.15% | -4,439.24% | -5,109.26% |
| 2024 | $509589.00 | $-4.90M | 99.85% | -923.34% | -962.12% |
| 2025 | $795950.00 | $-7.91M | 100.00% | -898.46% | -993.60% |